MDM2 and sarcoma: Patients with MDM2 positive group had better outcomes than MDM2 negative cases (p = 0.003, log‐rank, Figure 5D), thus stressing the importance of accurately diagnosing these lesions and distinguishing them from undifferentiated sarcomas.